PCSK9 Inhibitors and Cardiovascular Events
- PMID: 26287854
- DOI: 10.1056/NEJMc1508222
PCSK9 Inhibitors and Cardiovascular Events
Comment on
-
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15. N Engl J Med. 2015. PMID: 25773378 Clinical Trial.
-
PCSK9 Inhibitors and Cardiovascular Events.N Engl J Med. 2015 Aug 20;373(8):773. doi: 10.1056/NEJMc1508222. N Engl J Med. 2015. PMID: 26287855 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous